ResMed invites you to join us for our 2024 Investor Day
Join ResMed's management team online or in-person in New York City
Hear about ResMed's long-term growth strategy, market expansion opportunities,
product and solutions roadmap, and financial outlook
product and solutions roadmap, and financial outlook
September 30, 2024, 1:00 PM - 5:00 PM
Space for the event in NYC is limited; in-person attendance is by invitation only.
If you're interested in attending in person, please respond and indicate your interest. ResMed will confirm attendance starting in early September.
If you're interested in attending in person, please respond and indicate your interest. ResMed will confirm attendance starting in early September.
Webcast
The event will be webcast live for those not attending in person. Please visit investors.resmed.com for more information and to access the webcast on September 30, 2024.
Investor Day Schedule & Agenda
preliminary and subject to change
12:00 PM
Event check-in opens
Check-in will run from 12:00 PM - 1:00 PM. Give yourself plenty of time to get through NYSE security and join us for a light lunch and product showcase before the event begins.
1:00 PM
Welcome and Opening Remarks
Amy Wakeham, Chief Investor Relations Officer
Executive Presentations: ResMed 2030 Strategy
Mick Farrell, Chairman & Chief Executive Officer
Hemanth Reddy, Chief Strategy Officer
Justin Leong, Chief Product Officer
Bobby Ghoshal, Chief Commercial Officer, Software Business
Hemanth Reddy, Chief Strategy Officer
Justin Leong, Chief Product Officer
Bobby Ghoshal, Chief Commercial Officer, Software Business
Q&A session
ResMed executive team
2:50 PM
BREAK
3:00 PM
PANEL: Executive Discussion - Commercial Execution
Mike Fliss, Chief Revenue Officer
Katrin Pucknat, Chief Marketing Officer
Carlos Nunez, Chief Medical Officer
Moderated by: Mark Hayes, Breakwater Strategy
Katrin Pucknat, Chief Marketing Officer
Carlos Nunez, Chief Medical Officer
Moderated by: Mark Hayes, Breakwater Strategy
Financial Enablement & Growth Drivers
Brett Sandercock, Chief Financial Officer
Q&A Session
ResMed executive team
Panel: Medical Science & Sleep Apnea
Moderated by: Carlos Nunez, Chief Medical Officer
Closing remarks
Mick Farrell, Chairman & Chief Executive Officer
4:45 PM
Cocktail reception, Networking, Showcase
Questions? Contact Us
We hope you'll be able to attend our upcoming Investor Day. If you have any questions, don't hesitate to contact the ResMed Investor Relations team using the form on this page or send a message directly to [email protected].